• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WRN 解旋酶在 BRCA2 突变型癌细胞中保护去保护的复制叉。

WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells.

机构信息

Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD, 21224, USA.

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD, 21702, USA.

出版信息

Nat Commun. 2021 Nov 12;12(1):6561. doi: 10.1038/s41467-021-26811-w.

DOI:10.1038/s41467-021-26811-w
PMID:34772932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8590011/
Abstract

The tumor suppressor BRCA2 protects stalled forks from degradation to maintain genome stability. However, the molecular mechanism(s) whereby unprotected forks are stabilized remains to be fully characterized. Here, we demonstrate that WRN helicase ensures efficient restart and limits excessive degradation of stalled forks in BRCA2-deficient cancer cells. In vitro, WRN ATPase/helicase catalyzes fork restoration and curtails MRE11 nuclease activity on regressed forks. We show that WRN helicase inhibitor traps WRN on chromatin leading to rapid fork stalling and nucleolytic degradation of unprotected forks by MRE11, resulting in MUS81-dependent double-strand breaks, elevated non-homologous end-joining and chromosomal instability. WRN helicase inhibition reduces viability of BRCA2-deficient cells and potentiates cytotoxicity of a poly (ADP)ribose polymerase (PARP) inhibitor. Furthermore, BRCA2-deficient xenograft tumors in mice exhibited increased DNA damage and growth inhibition when treated with WRN helicase inhibitor. This work provides mechanistic insight into stalled fork stabilization by WRN helicase when BRCA2 is deficient.

摘要

抑癌基因 BRCA2 可保护停滞的复制叉不被降解,从而维持基因组稳定性。然而,BRCA2 缺陷细胞中未被保护的复制叉是如何被稳定下来的,其具体分子机制仍有待充分阐明。在这里,我们证明 WRN 解旋酶可确保复制叉的有效恢复,并限制 BRCA2 缺陷型癌细胞中停滞的复制叉的过度降解。在体外,WRN ATP 酶/解旋酶可催化复制叉的修复,并抑制 MRE11 核酸酶在退化复制叉上的活性。我们发现,WRN 解旋酶抑制剂将 WRN 捕获在染色质上,导致复制叉迅速停滞,并通过 MRE11 对未被保护的复制叉进行核酸酶降解,从而导致 MUS81 依赖性双链断裂、非同源末端连接增加和染色体不稳定。WRN 解旋酶抑制剂降低了 BRCA2 缺陷细胞的活力,并增强了聚(ADP-核糖)聚合酶(PARP)抑制剂的细胞毒性。此外,当用 WRN 解旋酶抑制剂处理时,BRCA2 缺陷型小鼠异种移植肿瘤显示出更多的 DNA 损伤和生长抑制。这项工作为 BRCA2 缺陷时 WRN 解旋酶稳定停滞复制叉提供了机制上的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/3346b01f9f54/41467_2021_26811_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/0174d049ca9f/41467_2021_26811_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/4cb3d27754e8/41467_2021_26811_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/9f8bd2b6f85c/41467_2021_26811_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/c5e2851c4ad1/41467_2021_26811_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/2d7b87a8f9cf/41467_2021_26811_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/6ab5fb2eb9d5/41467_2021_26811_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/5453ebcc83d0/41467_2021_26811_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/4c5be63cc651/41467_2021_26811_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/3346b01f9f54/41467_2021_26811_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/0174d049ca9f/41467_2021_26811_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/4cb3d27754e8/41467_2021_26811_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/9f8bd2b6f85c/41467_2021_26811_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/c5e2851c4ad1/41467_2021_26811_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/2d7b87a8f9cf/41467_2021_26811_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/6ab5fb2eb9d5/41467_2021_26811_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/5453ebcc83d0/41467_2021_26811_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/4c5be63cc651/41467_2021_26811_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/8590011/3346b01f9f54/41467_2021_26811_Fig9_HTML.jpg

相似文献

1
WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells.WRN 解旋酶在 BRCA2 突变型癌细胞中保护去保护的复制叉。
Nat Commun. 2021 Nov 12;12(1):6561. doi: 10.1038/s41467-021-26811-w.
2
WRN rescues replication forks compromised by a BRCA2 deficiency: Predictions for how inhibition of a helicase that suppresses premature aging tilts the balance to fork demise and chromosomal instability in cancer.WRN 可挽救 BRCA2 缺陷导致的复制叉受损:抑制抑制早衰的解旋酶如何打破平衡,导致癌症中叉崩溃和染色体不稳定性的预测。
Bioessays. 2022 Aug;44(8):e2200057. doi: 10.1002/bies.202200057. Epub 2022 Jun 25.
3
Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells. Cockayne 综合征 B 组蛋白调节 BRCA1/2 缺陷细胞中的叉重启、叉进展和 MRE11 依赖性叉降解。
Nucleic Acids Res. 2021 Dec 16;49(22):12836-12854. doi: 10.1093/nar/gkab1173.
4
Replication fork stability confers chemoresistance in BRCA-deficient cells.复制叉稳定性赋予BRCA缺陷细胞化学抗性。
Nature. 2016 Jul 21;535(7612):382-7. doi: 10.1038/nature18325.
5
PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells.PCAF 介导的组蛋白乙酰化通过 MRE11 和 EXO1 促进 BRCA 缺陷细胞中的复制叉降解。
Mol Cell. 2020 Oct 15;80(2):327-344.e8. doi: 10.1016/j.molcel.2020.08.018. Epub 2020 Sep 22.
6
Abro1 maintains genome stability and limits replication stress by protecting replication fork stability.Abro1通过保护复制叉稳定性来维持基因组稳定性并限制复制应激。
Genes Dev. 2017 Jul 15;31(14):1469-1482. doi: 10.1101/gad.299172.117.
7
MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells.MRE11核酸酶和EXO1核酸酶可降解反向叉状结构,并在BRCA2缺陷细胞中引发MUS81依赖的叉状结构挽救。
Nat Commun. 2017 Oct 16;8(1):860. doi: 10.1038/s41467-017-01180-5.
8
Phosphorylation-dependent WRN-RPA interaction promotes recovery of stalled forks at secondary DNA structure.磷酸化依赖性的WRN-RPA相互作用促进停滞的复制叉在二级DNA结构处的恢复。
Nat Commun. 2025 Jan 27;16(1):997. doi: 10.1038/s41467-025-55958-z.
9
UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells.UFL1 通过 MRE11 触发 BRCA1/2 缺陷细胞中的复制叉降解。
Nat Chem Biol. 2024 Dec;20(12):1650-1661. doi: 10.1038/s41589-024-01611-7. Epub 2024 Apr 22.
10
EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation.EZH2 通过招募 MUS81 并通过组蛋白 H3 三甲基化促进停滞复制叉的降解。
Nat Cell Biol. 2017 Nov;19(11):1371-1378. doi: 10.1038/ncb3626. Epub 2017 Oct 16.

引用本文的文献

1
Quinazoline Derivative kzl052 Suppresses Prostate Cancer by Targeting WRN Helicase to Stabilize DNA Replication Forks.喹唑啉衍生物kzl052通过靶向WRN解旋酶稳定DNA复制叉来抑制前列腺癌。
Int J Mol Sci. 2025 Jun 25;26(13):6093. doi: 10.3390/ijms26136093.
2
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR.通过联合抑制PKMYT1和ATR靶向CCNE1扩增的卵巢癌和子宫内膜癌。
Nat Commun. 2025 Apr 1;16(1):3112. doi: 10.1038/s41467-025-58183-w.
3
Novel De Novo Variant in an Early-Onset Ovarian Cancer Reveals a Unique Tumor Evolution Pathway.

本文引用的文献

1
Synthetic Lethal Interactions of RECQ Helicases.RECQ 解旋酶的合成致死相互作用。
Trends Cancer. 2021 Feb;7(2):146-161. doi: 10.1016/j.trecan.2020.09.001. Epub 2020 Oct 9.
2
Repeat expansions confer WRN dependence in microsatellite-unstable cancers.重复扩展赋予微卫星不稳定癌症对 WRN 的依赖性。
Nature. 2020 Oct;586(7828):292-298. doi: 10.1038/s41586-020-2769-8. Epub 2020 Sep 30.
3
Ubiquitinated-PCNA protects replication forks from DNA2-mediated degradation by regulating Okazaki fragment maturation and chromatin assembly.
早发性卵巢癌中的新型从头变异揭示了独特的肿瘤进化途径。
Int J Mol Sci. 2025 Mar 5;26(5):2295. doi: 10.3390/ijms26052295.
4
Phosphorylation-dependent WRN-RPA interaction promotes recovery of stalled forks at secondary DNA structure.磷酸化依赖性的WRN-RPA相互作用促进停滞的复制叉在二级DNA结构处的恢复。
Nat Commun. 2025 Jan 27;16(1):997. doi: 10.1038/s41467-025-55958-z.
5
To cleave or not and how? The DNA exonucleases and endonucleases in immunity.切割与否以及如何切割?免疫中的DNA外切核酸酶和内切核酸酶。
Genes Dis. 2024 Jan 24;12(2):101219. doi: 10.1016/j.gendis.2024.101219. eCollection 2025 Mar.
6
USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication.USP50在复制过程中抑制替代性RecQ解旋酶的使用及有害的DNA2活性。
Nat Commun. 2024 Sep 16;15(1):8102. doi: 10.1038/s41467-024-52250-4.
7
Replication stress as a driver of cellular senescence and aging.复制压力作为细胞衰老和老化的驱动因素。
Commun Biol. 2024 May 22;7(1):616. doi: 10.1038/s42003-024-06263-w.
8
Development of a Prognostic Risk Model Based on Oxidative Stress-related Genes for Platinum-resistant Ovarian Cancer Patients.基于氧化应激相关基因的铂耐药卵巢癌患者预后风险模型的建立
Recent Pat Anticancer Drug Discov. 2025;20(1):89-101. doi: 10.2174/0115748928311077240424065832.
9
New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement.DNA 双链断裂修复的新方面:辐射剂量是 HR 与 c-NHEJ 结合的关键决定因素。
Int J Mol Sci. 2023 Oct 6;24(19):14956. doi: 10.3390/ijms241914956.
10
A new wave of innovations within the DNA damage response.DNA 损伤反应领域的新一轮创新浪潮。
Signal Transduct Target Ther. 2023 Sep 8;8(1):338. doi: 10.1038/s41392-023-01548-8.
泛素化的 PCNA 通过调节冈崎片段成熟和染色质组装来保护复制叉免受 DNA2 介导的降解。
Nat Commun. 2020 May 1;11(1):2147. doi: 10.1038/s41467-020-16096-w.
4
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.聚腺苷二磷酸核糖聚合酶抑制剂耐药性:BRCA 突变细胞中的拔河比赛。
Trends Cell Biol. 2019 Oct;29(10):820-834. doi: 10.1016/j.tcb.2019.07.008. Epub 2019 Aug 14.
5
Defining and Modulating 'BRCAness'.定义和调节“BRCA 样特征”。
Trends Cell Biol. 2019 Sep;29(9):740-751. doi: 10.1016/j.tcb.2019.06.005. Epub 2019 Jul 27.
6
RIF1 promotes replication fork protection and efficient restart to maintain genome stability.RIF1 促进复制叉保护和有效重启动,以维持基因组稳定性。
Nat Commun. 2019 Jul 23;10(1):3287. doi: 10.1038/s41467-019-11246-1.
7
EXD2 Protects Stressed Replication Forks and Is Required for Cell Viability in the Absence of BRCA1/2.EXD2 保护应激复制叉,并且在没有 BRCA1/2 的情况下对细胞存活是必需的。
Mol Cell. 2019 Aug 8;75(3):605-619.e6. doi: 10.1016/j.molcel.2019.05.026. Epub 2019 Jun 26.
8
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.利用 CRISPR-Cas9 筛选技术对癌症治疗靶点进行优先级排序。
Nature. 2019 Apr;568(7753):511-516. doi: 10.1038/s41586-019-1103-9. Epub 2019 Apr 10.
9
WRN helicase is a synthetic lethal target in microsatellite unstable cancers.WRN 解旋酶是微卫星不稳定癌症的合成致死靶点。
Nature. 2019 Apr;568(7753):551-556. doi: 10.1038/s41586-019-1102-x. Epub 2019 Apr 10.
10
Rad52 prevents excessive replication fork reversal and protects from nascent strand degradation.Rad52 可防止复制叉过度反转,并防止新生链降解。
Nat Commun. 2019 Mar 29;10(1):1412. doi: 10.1038/s41467-019-09196-9.